Impact of screening and risk factors for local recurrence and survival after conservative surgery and radiotherapy for early breast cancer: Results from a large series with long-term follow-up

International Journal of Radiation Oncology Biology Physics

Volumn 83, Issue 3, 2012, Pages 829-838

  Kunkler, Ian H ^a   Kerr, Gillian R ^a   Thomas, Jeremy S ^a   Jack, Wilma J L ^a   Bartlett, John M S ^a   Pedersen, Hans C ^b   Cameron, David A ^a   Dixon, J Michael ^a   Chetty, Udi ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

^b DAKO ^*  (Denmark)

Author keywords

Breast screening; Breast conserving surgery; Breast conserving therapy; Postoperative radiotherapy

Indexed keywords

BREAST CANCER; BREAST CONSERVING SURGERY; BREAST SCREENING; BREAST-CONSERVING THERAPY; CLINICAL OUTCOME; CONFIDENCE INTERVAL; CONSERVATIVE SURGERY; CONSTANT RATE; DISTANT METASTASIS; EARLY BREAST CANCER; HORMONE RECEPTORS; IMMUNOHISTOCHEMISTRY; IPSILATERAL BREAST TUMOR RECURRENCE; LOCAL RECURRENCE; LONG-TERM FOLLOW-UP; POSTOPERATIVE RADIOTHERAPY; PROGNOSTIC FACTORS; PROGNOSTIC VARIABLES; PROPORTIONAL HAZARDS MODEL; RELAPSE RATES; RISK FACTORS; SURVIVAL RATE; TISSUE MICROARRAYS; TUMOR GRADES; TUMOR SIZE;

DISEASES; FISH; PATHOLOGY; RADIOTHERAPY; SURGERY; TUMORS;

DIAGNOSIS;

CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; ESTROGEN RECEPTOR; FLUOROURACIL; METHOTREXATE; PROGESTERONE RECEPTOR; TAMOXIFEN;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RELAPSE; CANCER RISK; CANCER SCREENING; CANCER SURGERY; CANCER SURVIVAL; CANCER TISSUE; COHORT ANALYSIS; CONSERVATIVE TREATMENT; DISTANT METASTASIS; EARLY CANCER; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IPSILATERAL BREAST TUMOR RECURRENCE; MAJOR CLINICAL STUDY; MASTECTOMY; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; TISSUE MICROARRAY; TUMOR VOLUME;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; COHORT STUDIES; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODES; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, SECOND PRIMARY; PROPORTIONAL HAZARDS MODELS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RISK FACTORS; TUMOR BURDEN; YOUNG ADULT;

EID: 84861592076     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.08.018     Document Type: Article

References (36)

1. U. Veronesi, A. Banfi, and B. Salvadori Breast conservation is the treatment of choice in small breast cancer: Long-term results of randomized trial Eur J Cancer 26 1990 668 670
2. J.A. van Dongen, H. Bartelink, and I.S. Fentiman Randomised clinical trial to assess the value of breast-conserving therapy in stage I and stage II breast cancer, EORTC 10801 trial J Natl Cancer Inst Monog 11 1992 15 18
3. U. Veronesi, R. Saccozzi, and M. Del Vecchio Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast N Engl J Med 305 1981 6 11
4. M. Aubele, S. Vidojkovic, and H. Braselmann Overexpression of PTK6 (breast tumor kinase) protein - a prognostic factor for long-term breast cancer survival - is not due to gene amplification Virchows Arch 455 2009 117 123
5. I.D. Nagtegaal, P.C. Allgood, and S.W. Duffy Prognosis and pathology of screen-detected carcinomas: How different are they? Cancer 117 2010 1360 1368
6. M.M. Roberts, F.E. Alexander, and T.J. Anderson The Edinburgh randomised trial of screening for breast cancer: Description of method Br J Cancer 50 1984 1 6
7. J.S. Thomas, G.R. Kerr, and W.J. Jack Histological grading of invasive breast carcinoma - a simplification of existing methods in a large conservation series with long-term follow-up Histopathology 55 2009 724 731
8. B.R. Leyland-Jones, C.B. Ambrosone, and J. Bartlett Recommendations for collection and handling of specimens from group breast cancer clinical trials J Clin Oncol 26 2008 5638 5644
9. U. Chetty, W. Jack, and R.J. Prescott Management of the axilla in operable breast cancer treated by breast conservation: A randomized clinical trial Br J Surg 87 2000 163 169
10. A. Price, W.J. Jack, and G.R. Kerr Acute radiation pneumonitis after postmastectomy irradiation: Effect of fraction size Clin Oncol 2 1990 224 229
11. C.J. Poole, H.M. Earl, and L. Hiller Epirubicin and cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy for early breast cancer New Engl J Med 355 2006 1851 1862
12. A. Moliterni, G. Bonadonna, and P. Valagussa Cyclophosphamide, methotrexate, and fluorouracil with and without doxorubicin in the adjuvant treatment of resectable breast cancer with one to three positive axillary nodes J Clin Oncol 9 1991 1124 1130
13. E.L. Kaplan, and P. Meier Nonparametric estimation from incomplete observations J Am Stat Assoc 53 1958 457 481
14. R. Peto, M.C. Pike, and P. Armitage Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples Br J Cancer 35 1977 1 39
15. D.R. Cox Regression models and life-tables J R Stat Soc B 34 1972 187 202
16. E.J. Rutgers Quality control in the locoregional treatment of breast cancer EUSOMA Consensus Group Eur J Cancer 37 2001 447 453
17. B. Kreike, H. Halfwerk, and N. Armstrong Local recurrence after breast-conserving therapy in relation to gene expression patterns in a large series of patients Clin Cancer Res 15 2009 4181 4190
18. Y. Komoike, F. Akiyama, and Y. Lino Ipsilateral breast tumor recurrence (IBTR) after breast-conserving treatment for early breast cancer: Risk factors and impact on distant metastases Cancer 106 2006 35 41
19. R.J. Santiago, W.U. Leester, and E. Harris Fifteen-year results of breast-conserving surgery and definitive irradiation for stage I and II breast carcinoma: The University of Pennsylvania experience Int J Rad Oncol Biol Phys 58 2004 233 240
20. M. Mannino, and J.R. Yarnold Local relapse rates are falling after breast conserving surgery and systemic therapy for early breast cancer: Can radiotherapy ever be safely withheld? Radiother Oncol 90 2009 14 22
21. M.F. Ernst, A.C. Voogd, and J.W. Coebergh Using loco-regional recurrence as an indicator of the quality of breast cancer treatment Eur J Cancer 40 2004 487 493
22. U. Veronesi, E. Marubini, and M. Del Vecchio Local recurrences and distant metastases after conservative breast cancer treatments: Partly independent events J Natl Cancer Inst 87 1995 19 27
23. A. de la Rochefordiere, B. Asselain, and F. Campana Age as prognostic factor in premenopausal breast cancer Lancet 341 1993 1039 1043
24. B.L. Fowble, D.J. Schultz, and B. Overmoyer The influence of young age on outcome in early stage breast cancer Int J Rad Oncol Biol Phys 30 1994 23 33
25. A.P. Locker, I.O. Ellis, and D.A. Morgan Factors influencing local recurrence after excision and radiotherapy for primary breast cancer Br J Surg 76 1989 890 894
26. G.M. Freedman, A.L. Hanlon, and B.L. Fowble Recursive partitioning identifies patients at high and low risk for ipsilateral tumor recurrence after breast-conserving surgery and radiation J Clin Oncol 20 2002 4015 4021
27. J.J. Jobsen, J. van der Palen, and J.H. Meerwaldt The impact of age on local control in women with pT1 breast cancer treated with conservative surgery and radiation therapy Eur J Cancer 37 2001 1820 1827
28. R. Arriagada, M.G. Lê, and G. Contesso Predictive factors for local recurrence in 2006 patients with surgically resected small breast cancer Ann Oncol 13 2002 1404 1413
29. A.C. Voogd, M. Nielsen, and J.L. Peterse Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: Pooled results of two large European randomized trials J Clin Oncol 19 2001 1688 1697
30. E. Touboul, L. Buffat, and Y. Belkacémi Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer Int J Rad Oncol Biol Phys 43 1999 25 38
31. L.D. Wilson, M. Bienfield, and C.F. McKhann Conservative surgery and radiation in the treatment of synchronous ipsilateral breast cancers Cancer 72 1993 137 142
32. P.M. Ravdin, S. Green, and T.M. Dorr Prognostic significance of progesterone receptor levels in estrogen receptor-positive patients with metastatic breast cancer treated with tamoxifen: Results of a prospective Southwest Oncology Group study J Clin Oncol 10 1992 1284 1291
33. The Breast Screening Frequency Trial Group The frequency of breast cancer screening: Results from the UKCCCR Randomised Trial Eur J Cancer 38 2002 1458 1464
34. A.J. Coldman, N. Phillips, and I.A. Olivotto Impact of changing from annual to biennial mammographic screening on breast cancer outcomes in women aged 50-79 in British Columbia J Med Screen 15 2008 182 187
35. D.A. Paterson, T.J. Anderson, and W.J. Jack Pathological features predictive of local recurrence after management by conservation of invasive breast cancer: Importance of non-invasive carcinoma Radiother Oncol 25 1992 176 180
36. A. Neri, D. Marrelli, and S. Rossi Breast cancer local recurrence: Risk factors and prognostic relevance of early time to recurrence World J Surg 31 2007 36 45